Etilevodopa Explained
Etilevodopa (TV-1203) is a dopaminergic agent which was developed as a treatment for Parkinson's disease.[1] It is the ethyl ester of levodopa. It was never marketed.
See also
Notes and References
- Djaldetti R, Giladi N, Hassin-Baer S, Shabtai H, Melamed E . Pharmacokinetics of etilevodopa compared to levodopa in patients with Parkinson's disease: an open-label, randomized, crossover study . Clinical Neuropharmacology . 26 . 6 . 322–6 . November–December 2003 . 14646613 . 10.1097/00002826-200311000-00012 . 23992241 .